Geneyx and Ocean Genomics Collaborate to Enhance Genomic Variant Detection for Improved Disease Diagnosis and Drug Target Identification
26/07/2023 – Herzlia, Israel: Geneyx, a leading genomic analysis company, and Ocean Genomics announced they were awarded a grant from the BIRD Foundation to develop a cutting-edge MultiOmic software method. This joint effort combine’s DNA and RNA technologies, revolutionizing the detection of genomic variants, advancing disease diagnosis and drug target identification.
This will have far-reaching implications for personalized medicine, allowing for the identification of drug targets and tailored treatment plans.
“We are thrilled to receive the grant from the Bird Foundation and collaborate with Ocean Genomics on this groundbreaking project. Integrating DNA and RNA technologies to create a MultiOmic software method holds tremendous potential for improving disease diagnosis and identifying drug targets. This advancement will pave the way for personalized medicine, enabling us to develop tailored treatment plans based on individual genetic profiles.”
David Yizhar, CEO of Geneyx
“Many diseases are caused by structural variants, but they can be difficult to detect, and many are missed in testing only DNA or RNA alone. By deeply integrated analysis of a patient’s DNA and RNA together, we can identify more of these variants, improve diagnosis, and determine targets for new therapies. Many thanks to the BIRD Foundation for recognizing the importance of this innovation and supporting us to develop and bring these this solution to market in collaboration with Geneyx.”
Carl Kingsford, CEO Ocean Genomics
“Congratulations to Geneyx and Ocean Genomics on receiving the grant from the BIRD Foundation to support their joint project. Their innovative MultiOmic software technique has the potential to revolutionize the field of genomics and significantly contribute to the diagnosis of diseases and identification of drug targets.”
Jaron Lotan, Executive Director of the BIRD Foundation
About Ocean Genomics: Ocean Genomics provides a data and AI platform for advancing drug discovery though the integration of transcriptomic information. Its Intelligent Transcriptome™ hosts over 100,000 transcriptomic samples, many pre-trained models, and a vast and growing molecular knowledge graph. The Intelligent Transcriptome™ enables biopharma partners to discover new targets, signatures, and biomarkers, determine biological impact and MoA, and enable drug rescue and repurposing.
About The BIRD Foundation: A renowned organization dedicated to promoting collaboration and innovation between Israeli and American companies in various industries. It provides grants and funding opportunities to support joint research and development projects, fostering technological advancements and business partnerships. With a focus on promoting cross-border cooperation, the BIRD Foundation plays a crucial role in driving economic growth and knowledge exchange between Israel and the United States.